Condition
Coronary Artery Disease (CAD)
Coronary artery disease is a buildup of plaque in the heart's arteries that narrows them, reduces blood flow and raises heart attack risk. Omega-3s and coenzyme Q10 have the strongest standing, yet small trials found coenzyme Q10 raised antioxidant enzyme activity, and fish oil gave mixed results for atrial fibrillation after bypass surgery. Those studies were few and small, so the evidence behind them is limited.
Sources: PMID 21996047; PMID 28419884
- Supplements studied
- 24
- Graded outcomes
- 23
- Trials
- 38
- People studied
- 56,497
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Mixed effect | 2 studies | 164 people | ||||
| Glutathione (GSH) | Improves (the measure goes up) | 120 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 120 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 164 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 120 people | ||||
Saffron
- Blood glucose: improves
- Weight: improves
- Triglycerides: improves
Flaxseed
- Blood glucose: improves
- C-Reactive Protein (CRP): improves
- Triglycerides: improves
Magnesium
- C-Reactive Protein (CRP): improves
- Serum Magnesium: improves
- Homocysteine: improves
Coenzyme Q10
- Anti-Oxidant Enzyme Profile: improves
- Oxidative Stress Biomarkers: improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 2 studies | 103 people | ||
Studies that measured anti-oxidant enzyme profile | ||||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 9 studies | 247 people | |||
Studies that measured oxidative stress biomarkers
| ||||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 144 people | |||
Studies that measured low-density lipoprotein (ldl)
| ||||||
| Interleukin 6 | Improves (the measure goes down) | 2 studies | 60 people | |||
Studies that measured interleukin 6
| ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 144 people | |||
Studies that measured total cholesterol | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 144 people | |||
| Cardiovascular Disease Mortality | Improves (the measure goes down) | 144 people | ||||
| Endogenous Advanced Glycation End Products | Improves (the measure goes up) | 60 people | ||||
| Lipoprotein(a) | Improves (the measure goes up) | 60 people | ||||
| Plasma Vitamin C | Improves (the measure goes up) | 144 people | ||||
| Plasma Vitamin E | Improves (the measure goes up) | 144 people | ||||
| Stroke Risk | Changes; see studies | 144 people | ||||
| Triglycerides | Improves (the measure goes down) | 144 people | ||||
Fish Oil
- Atrial Fibrillation Incidence
- Triglycerides: improves
- High-density lipoprotein (HDL): improves
Resveratrol
- Blood Flow: improves
- Blood glucose: improves
- C-Reactive Protein (CRP): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 1 study | 40 people | ||
Studies that measured blood flow | ||||||
| Blood glucose | Improves (the measure goes down) | 7 studies | 871 people | |||
Studies that measured blood glucose
| ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 147 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 911 people | |||
| Vascular Function | Improves (the measure goes up) | 2 studies | 1,034 people | |||
Studies that measured vascular function
| ||||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 871 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 40 people | ||||
| Insulin | Changes; see studies | 871 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 871 people | ||||
| Intercellular Adhesion Molecule 1 | Changes; see studies | 1,034 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 225 people | ||||
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 40 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 911 people | ||||
| Plasminogen Inhibitor-1 | Improves (the measure goes up) | 1,034 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 658 people | ||||
Pycnogenol
- Blood Flow: improves
- Blood Pressure: changes; see studies
- Heart Rate: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Moderate Increase | Improves (the measure goes up) | Moderate effect | 1 study | 23 people | ||
Studies that measured blood flow | ||||||
| Blood Pressure | Changes; see studies | 2 studies | 23 people | |||
Studies that measured blood pressure | ||||||
| Heart Rate | Changes; see studies | 1 study | 23 people | |||
| C-Reactive Protein (CRP) | Changes; see studies | 23 people | ||||
| Inflammation | Changes; see studies | 23 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 23 people | ||||
Terminalia Arjuna
- Heart Size: improves
- Left Ventricular Ejection Fraction: improves
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Heart Size Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 10 people | ||
Studies that measured heart size | ||||||
| Left Ventricular Ejection Fraction Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 10 people | ||
Studies that measured left ventricular ejection fraction | ||||||
| Liver Enzymes | Changes; see studies | 10 people | ||||
Pterostilbene
- Blood Pressure: improves
- Weight: improves
- High-density lipoprotein (HDL): worsens
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 80 people | |||
| Weight | Improves (the measure goes down) | 1 study | 80 people | |||
Studies that measured weight | ||||||
| High-density lipoprotein (HDL) Small Detriment | Worsens (the measure goes down) | Small effect | 80 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 80 people | ||||
| Total cholesterol | Improves (the measure goes down) | 80 people | ||||
| Triglycerides | Improves (the measure goes down) | 80 people | ||||
Vitamin D
- Body Fat: improves
- Low-density lipoprotein (LDL): improves
- Risk Of Cardiovascular Disease: improves
Berberine
- C-Reactive Protein (CRP): improves
- Total cholesterol: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 120 people | |||
| Total cholesterol | Improves (the measure goes down) | 3 studies | 689 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 2 studies | 589 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 689 people | |||
| Interleukin 6 | Improves (the measure goes down) | 240 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 689 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 240 people |
D-Ribose
- Angina: improves
- ATP Regeneration: improves
- Exercise Capacity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Angina Small Improvement | Improves (the measure goes up) | Small effect | 20 people | |||
| ATP Regeneration | Improves (the measure goes up) | 2 studies | 15 people | |||
| Exercise Capacity | Improves (the measure goes up) | 2 studies | 35 people | |||
| Atrial Contribution To Left Ventricular Filling | Improves (the measure goes up) | 15 people | ||||
| E wave deceleration time | Improves (the measure goes up) | 15 people | ||||
| End-Systolic Volume | Improves (the measure goes up) | 15 people | ||||
| Exercise Tolerance | Improves (the measure goes up) | 35 people | ||||
| Left Atrial Dimension | Improves (the measure goes up) | 15 people | ||||
| Left Ventricular Diastolic Dimension | Improves (the measure goes up) | 15 people | ||||
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 15 people | ||||
| Quality of Life | Improves (the measure goes up) | 15 people |
Betaine
- Apolipoprotein A: improves
- Homocysteine: changes; see studies
- Fibrinogen: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A Small Increase | Improves (the measure goes up) | Small effect | 27 people | |||
| Homocysteine | Changes; see studies | 4 studies | 27 people | |||
| Fibrinogen | Improves (the measure goes up) | 1 study | 27 people | |||
| Total cholesterol | Changes; see studies | 1 study | 27 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 27 people | ||||
| LDL Oxidation | Changes; see studies | 27 people | ||||
| Liver Enzymes | Changes; see studies | 27 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 27 people | ||||
| Plasminogen Inhibitor-1 | Improves (the measure goes up) | 27 people |
Ginkgo Biloba
- Anti-Oxidant Enzyme Profile
- Atherosclerotic Signs: improves
- Nitric Oxide: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Mixed effect | 8 people | |||||
| Atherosclerotic Signs | Improves (the measure goes up) | 1 study | 8 people | |||
| Nitric Oxide | Improves (the measure goes up) | 1 study | 8 people | |||
| Apolipoprotein A | Improves (the measure goes up) | 8 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 8 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 8 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 8 people | ||||
| Myeloperoxidase | Improves (the measure goes up) | 8 people |
Conjugated Linoleic Acid
- High-density lipoprotein (HDL)
- Low-density lipoprotein (LDL): improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) No effect | NoneNo effect | 6 studies | 61 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 6 studies | 61 people | |||
| Weight | Improves (the measure goes down) | 6 studies | 61 people |
Vitamin E
- High-density lipoprotein (HDL)
- Oxidative Stress Biomarkers: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) No effect | NoneNo effect | 1 study | 35 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 70 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 35 people | |||
| Triglycerides | Improves (the measure goes down) | 2 studies | 35 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 35 people |
Niacin (Vitamin B3)
- Cardiovascular Disease Mortality
- Total cholesterol: improves
- Heart Attack Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cardiovascular Disease Mortality No effect | NoneNo effect | 1 study | 2,840 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 2,840 people | |||
| Heart Attack Risk | Changes; see studies | 2,840 people | ||||
| Triglycerides | Improves (the measure goes down) | 2,840 people |
Cocoa Extract
- C-Reactive Protein (CRP)
- High-density lipoprotein (HDL): improves
- Platelet Aggregation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 1 study | 28 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 13 studies | 28 people | |||
| Platelet Aggregation | Changes; see studies | 2 studies | 28 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 28 people |
Rose Hip
- Adiponectin
- C-Reactive Protein (CRP): improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 31 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 31 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 31 people | |||
| Blood glucose | Improves (the measure goes down) | 31 people | ||||
| Blood Pressure | Improves (the measure goes down) | 31 people | ||||
| HbA1c | Improves (the measure goes down) | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 31 people | ||||
| Insulin | Changes; see studies | 31 people | ||||
| Liver Enzymes | Changes; see studies | 31 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 31 people | ||||
| Total cholesterol | Improves (the measure goes down) | 31 people | ||||
| Triglycerides | Improves (the measure goes down) | 31 people | ||||
| Weight | Improves (the measure goes down) | 31 people |
L-Carnitine
- Apolipoprotein A
- High-density lipoprotein (HDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A No effect | NoneNo effect | 47 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 12 studies | 47 people | |||
| Total cholesterol | Improves (the measure goes down) | 6 studies | 47 people | |||
| Triglycerides | Improves (the measure goes down) | 4 studies | 47 people | |||
| Muscle Mass | Improves (the measure goes up) | 3 studies | 75 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 75 people | |||
| Interleukin 6 | Improves (the measure goes down) | 2 studies | 47 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 47 people | |||
| Blood Pressure | Improves (the measure goes down) | 1 study | 75 people | |||
| Body Fat | Improves (the measure goes down) | 1 study | 75 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 47 people | |||
| Myeloperoxidase | Improves (the measure goes up) | 1 study | 75 people | |||
| Weight | Improves (the measure goes down) | 1 study | 75 people | |||
| Apolipoprotein B | Improves (the measure goes down) | 47 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 47 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 47 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 75 people |
Creatine
- Homocysteine: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Homocysteine | Improves (the measure goes down) | 1 study | 19 people |
Black seed
- Vascular Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Vascular Function | Improves (the measure goes up) | 1 study | 146 people |
Key findings
- C-Reactive Protein (CRP)
- Blood glucoseImproves (the measure goes down)
- Anti-Oxidant Enzyme ProfileImproves (the measure goes up)
The Coronary Artery Disease (CAD) protocol
2 primary supplements · 2 supporting supplements
- Omega-3 Fatty Acids2–4 g EPA/DHA daily
- Coenzyme Q10100–300 mg daily
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Coronary Artery Disease (CAD). If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplement graded A or B for Coronary Artery Disease (CAD). Each opens third-party tested products for that supplement.
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
8 studies from PubMed
- Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk
- The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease
- Effect of garlic (Allium sativum) oil on exercise tolerance in patients with coronary artery disease
- Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease
- The antiinflammatory effects of purple grape juice consumption in subjects with stable coronary artery disease
- Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial
- Anti-Inflammatory Effects of a Vegan Diet Versus the American Heart Association-Recommended Diet in Coronary Artery Disease Trial
- Plant-based, no-added-fat or American Heart Association diets: impact on cardiovascular risk in obese children with hypercholesterolemia and their parents